Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1

NCT06007391 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT06007391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06007391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1
Lead sponsor
University Hospital, Angers
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
January 23, 2024
Completion date
September 30, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotinamide adverse reaction